A simple, once-daily dosing regimen for treating HIV-1 infection in intravenous drug users.
Staszewski
S
S
Klinikum der Johann Wolfgang Goethe-Universität, Zentrum der Inneren Medizin, Medizinische Klinik III, Infektiologie, Theodor-Stern-Kai 7, Frankfurt, Germany.
Haberl
A
A
Carlebach
A
A
Rottmann
C
C
Miller
V
V
Gute
P
P
D019380:Anti-HIV Agents / Q000008:administration & dosage*; D015496:CD4-Positive T-Lymphocytes; D016049:Didanosine / Q000008:administration & dosage; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D015658:HIV Infections / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D019259:Lamivudine / Q000008:administration & dosage; D019829:Nevirapine / Q000008:administration & dosage; D010865:Pilot Projects; D016133:Polymerase Chain Reaction; D012367:RNA, Viral / Q000302:isolation & purification; D015819:Substance Abuse, Intravenous / Q000150:complications*; D016312:Treatment Refusal; D019562:Viral Load
D019380:Anti-HIV Agents; D012367:RNA, Viral; D019259:Lamivudine; D019829:Nevirapine; D016049:Didanosine